CG Oncology, Inc. (CGON) Reports Q3 Loss, Tops Revenue Estimates

CG Oncology, Inc. (CGON) came out with a quarterly loss of $0.57 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.3 per share a year ago. These figures are adjusted for non-recurring items. A quarter ago, it was expected that this company would post a loss of $0.49 per share when it actually produced a loss of $0.54, delivering a surprise of -10.2%.Over the last four quarters, the company has not been able to surpass consensus EPS estimates.CG Oncology, Inc., which belongs ...